Total Funding
27
Total FundingVenture - Series Unknown raised
Growth Score in past quarter
pts
Heat Score 27 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
530490
Life-saving medicines for cancer patients around the world.
About the Company
Anew Oncology, Inc. (“Anew”, “AOI”, or the Company) is a private, commercial-stage specialty oncology company founded with a vision to build a portfolio of more affordable, life-saving medicines for cancer patients around the world. Lower cost, more affordable and life-saving drugs are now an imminent reality in the global oncology market due to
prior and upcoming patent expirations on several blockbuster anti-cancer drugs. Unlike other “generic drugs”
